Source | hl7.fhir.us.sirb#current:Single Institutional Review Board (sIRB) Implementation Guide (v4.0.1) |
resourceType | Questionnaire |
id | sirb-initiate-study-questionnaire-populate |
canonical | http://hl7.org/fhir/us/sirb/Questionnaire/sirb-initiate-study-questionnaire-populate |
version | 1.0.0 |
status | draft |
publisher | HL7 International - BR&R Work Group |
name | SIRBInitiateAStudyQuestionnaire |
title | Initiate a Study Questionnaire |
date | 2023-03-29T06:17:19+00:00 |
description | Initiate a Study Questionnaire |
jurisdictions | us |
Usages | (none) |
Research Study Details
Study Title *
The official title of a protocol used to identify a clinical study.Include phase (e.g. pilot proof of concept study, phase I, phase II, etc.), design (e.g. randomized, double blind, placebo controlled, etc.), if the study is multi-center, the investigational agent (drug, device, biologic, vaccine, procedural and/or behavioral etc., and target disease(s)
Study Title (Short) *
A short study title written in language intended for the lay public.
IRB Protocol Number *
The Protocol Number assigned by the sIRB
Study Type *
Select the study type, either Interventional (Clinical Trial) or Observational (Non-Interventional)
Other Organization(s) Involved
Relationship Type *
Select the organization's type of involvement in the study
Organization Name *
e.g. NIH or company name
Phone
10 digit phone number, including area code
Sponsor or Funding Source Protocol Number, if applicable
Unique Protocol Identification Number used by the sponsor, if applicable
Other Organization Name, Relationship Type, Phone and Protocol Number (read-only)
sIRB (Reviewing Institution)
sIRB (Reviewing Institution) Name *
Name of the sIRB (Reviewing Institution)
Department Name or Division
The department name or division of the sIRB, if applicable
Institution Street Address *
Physical address of the sIRB (Reviewing Institution)
Institution City *
Institution State *
Institution Zip Code *
Institution Country
Is a Federal Wide Assurance (FWA) Number assigned? *
DHHS assigned number indicating Assurance of Compliance with the Office of Human Research Protections. The only type of assurance of compliance accepted and approved by OHRP for institutions engaged in non-exempt human subjects research conducted or supported by HHS. Under a FWA, an institution commits to HHS that it will comply with the requirements set forth in 45 CFR 46, as well as the terms of assurance. If the user believes that there is a FWA number assigned but needs to confirm this, select "temporarily unavailable". If the user does not know if there is a FWA number assigned, select "No Information".
Federal Wide Assurance Number (if assigned)
If assigned, enter just numeric value of FWA.
Is the sIRB a 3rd party institution?
Is the sIRB an external 3rd party institution, outside of the lead Principal Investigator institution?
Lead Principal Investigator
Lead Principal Investigator Institution
Lead Principal Investigator Institution Name *
Name of institution for the lead principal investigator
Department Name or Division
The department name or division of the lead principal investigator
Institution Phone
10-digit phone number, including area code, for the institution of the lead principal investigator
Is a Federal Wide Assurance (FWA) Number assigned? *
DHHS assigned number indicating Assurance of Compliance with the Office of Human Research Protections. The only type of assurance of compliance accepted and approved by OHRP for institutions engaged in non-exempt human subjects research conducted or supported by HHS. Under a FWA, an institution commits to HHS that it will comply with the requirements set forth in 45 CFR 46, as well as the terms of assurance. If the user believes that there is a FWA number assigned but needs to confirm this, select "temporarily unavailable". If the user does not know if there is a FWA number assigned, select "No Information".
Federal Wide Assurance Number (if assigned)
If assigned, enter just numeric value of FWA.
Lead Principal Investigator
Lead Principal Investigator First Name *
First Name or Given Name of the lead PI responsible for the overall study
Lead Principal Investigator Last Name *
Last name, surname or family name of the lead PI responsible for the overall study
Lead Principal Investigator Suffix
Suffix such as Junior (Jr.), Senior (Sr.), I, II, III, IV, etc.
Academic and Professional Degrees associated with the Lead Principal Investigator *
Academic and Professional degrees associated with the lead principal investigator
Department Name or Division
The department name or division of the lead PI
Phone
10-digit phone number, including area code, for the lead principal investigator
Email address
Email address associated with the lead principal investigator
Address of Lead Principal Investigator
Street Address
Physical address
City *
State *
Zip Code
Country
Relying Site(s)
Affiliation with Lead Principal Investigator Institution, Lead Principal Investigator Site or Lead Principal Investigator
Is this relying site at the same institution as where the lead principal investigator is conducting the study?
This question is optional. It can be used to pre-populate the lead principal investigator institution details if this relying site is at the same institution as where the lead principal investigator is conducting the study. If you do not want pre-population to occur, you may leave this question blank.
Is this relying site at the same site as where the lead principal investigator is conducting the study?
This question is optional. It can be used to pre-populate the lead principal investigator site details if this relying site is at the same site as where the lead principal investigator is conducting the study. If you do not want pre-population to occur, you may leave this question blank.
Is the relying site PI for this site the same PI as the lead principal investigator conducting the study?
This question is optional. It can be used to pre-populate the lead principal investigator details if this relying site PI is the same PI as the lead principal investigator conducting the study. If you do not want pre-population to occur, you may leave this question blank.
Is this relying site also considered to be the lead site for the study? *
Indicator that the lead PI site where the study is being conducted is also participating as this relying site
Relying Site Institution
Relying Institution Name *
Name of Institution for which their IRB agrees to rely on the decisions of the reviewing IRB at their own institutions.
Department Name or Division
The department name or division for the relying site
Relying Institution Phone
10-digit phone number, including area code, for the relying institution
Is a Federal Wide Assurance (FWA) Number assigned? *
DHHS assigned number indicating Assurance of Compliance with the Office of Human Research Protections. The only type of assurance of compliance accepted and approved by OHRP for institutions engaged in non-exempt human subjects research conducted or supported by HHS. Under a FWA, an institution commits to HHS that it will comply with the requirements set forth in 45 CFR 46, as well as the terms of assurance. If the user believes that there is a FWA number assigned but needs to confirm this, select "temporarily unavailable". If the user does not know if there is a FWA number assigned, select "No Information".
Federal Wide Assurance Number (if assigned)
If assigned, enter just numeric value of FWA.
Reliance Status *
Status of the reliance agreement
Institution whose IRB agrees to rely on oversite by the sIRB (Reviewing IRB)
Relying Site Principal Investigator
Relying Site Principal Investigator First Name *
First Name or Given Name of PI at a site conducting the study, responsible for the conduct of the study at his/her relying institution
Relying Site Principal Investigator Last Name *
Last name, surname or family name of PI at a site conducting the study, responsible for the conduct of the study at his/her relying institution
Relying Site Principal Investigator Suffix
Suffix such as Junior (Jr.), Senior (Sr.), I, II, III, IV, etc.
Academic and Professional Degrees associated with the Relying Site Principal Investigator
Academic and Professional degrees associated with the relying site principal investigator
Department Name or Division
The department name or division for the relying site PI
Phone
10-digit phone number, including area code, for the relying site principal investigator
Email address
Email address associated with the relying site principal investigator
Address of Relying Site Principal Investigator
Street Address
Physical address
City
State
Zip Code
Country
Principal Investigator responsible for the conduct of the study at a specific relying site research location.
Relying Site Principal Investigator Name, Institution, Dept, City and State (read-only)
The research site(s) where the Lead Principal Investigator is conducting research should also be entered as relying site(s) here, even if at the same institution as entered above for the Lead Principal Investigator. If the Lead Principal Investigator is only managing a coordinating center or other administrative office for the study, do not enter the site again here.
FDA exemption and IDE/IND Number
Does this study require a FDA exemption?
Indicator for use of FDA regulated product
Is an IND or IDE being used in this study?
Is an Investigational New Drug (IND) or Investigational Device Exemption (IDE) being used?
Please select IND or IDE:
Select IND for Investigational New Drug or IDE for Investigational Device Exemption
IND/IDE Number
Questionnaire Version Details
Questionnaire Version *
Questionnaire Version Date *
Questionnaire Response ID for the parent Questionnaire Response (such as the Initiate a Study Questionnaire Response), if any
ID of the Research Study FHIR Resource associated with the study Questionnaire Responses
Produced 06 Apr 2023